ClinicalTrials.govpublic full text
Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
cytokine release syndrome, neoplasms, lymphoma, precursor cell lymphoblastic leukemia-lymphoma, multiple myeloma, lymphoma mantle-cell, immunotherapy, cell and tissue-based therapy, cytokines, monitoring physiologic, immune monitoring, wearable electronic devices
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 857835
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.